Back

Deeplearning based MHC epitope prediction for cancer neoantigen discovery

Xie, C.; Shi, Y.; Zhang, C.

2021-11-13 bioinformatics
10.1101/2021.11.10.468160 bioRxiv
Show abstract

Neoantigens are important for cancer immunotherapies or cancer vaccine development, but identification of neoantigens is challenging. The high binding affinity between the mutated peptide and MHC (major histocompatibility complex) molecules of the patients is a necessary factor for a somatic mutation on the tumor genome to form a neoantigen. MHC epitope prediction tools can be used for the identification of neoantigens. This research investigates MHC epitope prediction by utilizing Tri-peptide similarity as features for the XGBoost classifier. This model was tested on experimentally validated cancer neoantigen peptides.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.